AA Morley

1.8k total citations
23 papers, 1.5k citations indexed

About

AA Morley is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, AA Morley has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in AA Morley's work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). AA Morley is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). AA Morley collaborates with scholars based in Australia, China and Estonia. AA Morley's co-authors include KJ Trainor, MJ Brisco, M. J. Brisco, Indra Ramasamy, S. H. Neoh, Scott Grist, Alexander Dobrovic, Pamela J. Sykes, Elizabeth Hughes and Gaynor Dolman and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

AA Morley

22 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AA Morley Australia 16 743 462 451 389 288 23 1.5k
KJ Trainor Australia 14 756 1.0× 427 0.9× 528 1.2× 257 0.7× 360 1.3× 19 1.6k
Cherie H. Dunphy United States 24 817 1.1× 519 1.1× 683 1.5× 443 1.1× 270 0.9× 127 2.0k
Anne Lennard United Kingdom 20 831 1.1× 562 1.2× 561 1.2× 414 1.1× 240 0.8× 51 1.6k
D Filippa United States 21 969 1.3× 608 1.3× 706 1.6× 297 0.8× 263 0.9× 34 1.6k
CW Berard United States 22 1.2k 1.6× 428 0.9× 672 1.5× 252 0.6× 266 0.9× 34 1.7k
DC Linch United Kingdom 19 949 1.3× 397 0.9× 720 1.6× 229 0.6× 241 0.8× 37 1.5k
Gerald E. Byrne United States 27 1.4k 1.8× 575 1.2× 959 2.1× 204 0.5× 475 1.6× 48 2.3k
DY Mason United Kingdom 10 770 1.0× 266 0.6× 458 1.0× 231 0.6× 438 1.5× 13 1.3k
Marco Fizzotti Italy 17 1.4k 1.8× 479 1.0× 876 1.9× 243 0.6× 459 1.6× 38 2.0k
Bachir Alobeid United States 24 691 0.9× 296 0.6× 635 1.4× 279 0.7× 559 1.9× 92 1.7k

Countries citing papers authored by AA Morley

Since Specialization
Citations

This map shows the geographic impact of AA Morley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AA Morley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AA Morley more than expected).

Fields of papers citing papers by AA Morley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AA Morley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AA Morley. The network helps show where AA Morley may publish in the future.

Co-authorship network of co-authors of AA Morley

This figure shows the co-authorship network connecting the top 25 collaborators of AA Morley. A scholar is included among the top collaborators of AA Morley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AA Morley. AA Morley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
FitzGerald, John, et al.. (2013). Micro-ribonucleic acids in head and neck cancer: an introduction. The Journal of Laryngology & Otology. 127(S2). S2–S7. 3 indexed citations
2.
Morley, AA, et al.. (2012). Transoral robotic surgery for removal of a second branchial arch cyst: a case report. Journal of Robotic Surgery. 6(4). 349–353. 13 indexed citations
3.
Ross, David M., et al.. (2011). Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features. Haematologica. 96(11). 1720–1722. 20 indexed citations
4.
Brisco, MJ, Pamela J. Sykes, E. Jane Hughes, et al.. (2001). Comparison of methods for assessment of minimal residual disease in childhood B-lineage acute lymphoblastic leukemia. Leukemia. 15(3). 385–390. 17 indexed citations
5.
Morley, AA, et al.. (1997). Leukaemia presenting as marrow hypoplasia: molecular detection of the leukaemic clone at the time of initial presentation. British Journal of Haematology. 98(4). 940–844. 9 indexed citations
6.
Brisco, M. J., Pamela J. Sykes, Elizabeth Hughes, et al.. (1997). Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemia. British Journal of Haematology. 99(2). 314–319. 55 indexed citations
7.
Brisco, MJ, Pamela J. Sykes, Gaynor Dolman, et al.. (1997). Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia. Leukemia. 11(9). 1497–1500. 19 indexed citations
8.
Sykes, Pamela J., MJ Brisco, S. H. Neoh, et al.. (1997). The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood. Leukemia. 11(1). 153–158. 21 indexed citations
9.
Hughes, Elizabeth, S. H. Neoh, Pamela J. Sykes, et al.. (1996). Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood. 87(12). 5251–5256. 82 indexed citations
11.
Ramasamy, Indra, et al.. (1992). Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms.. Journal of Clinical Pathology. 45(9). 770–775. 232 indexed citations
12.
Trainor, KJ, et al.. (1991). Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction [see comments]. Blood. 78(1). 192–196. 287 indexed citations
13.
Trainor, KJ, et al.. (1990). Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood. 75(11). 2220–2222. 226 indexed citations
14.
Trainor, KJ, et al.. (1990). Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood. 75(11). 2220–2222. 16 indexed citations
15.
Roxby, David, R. Seshadri, Carol M. Ashton, & AA Morley. (1988). A DIRECT PATIENT APPROACH FOR PRE‐OPERATIVE AUTOLOGOUS BLOOD DONATION AND TRANSFUSION. Australian and New Zealand Journal of Surgery. 58(6). 471–473. 1 indexed citations
16.
Dobrovic, Alexander, KJ Trainor, & AA Morley. (1988). Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. Blood. 72(6). 2063–2065. 64 indexed citations
17.
Gallus, Alexander, et al.. (1985). INTERMITTENT CLAUDICATION: A DOUBLE–BLIND CROSSOVER TRIAL OF PENTOXIFYLLINE. Australian and New Zealand Journal of Medicine. 15(4). 402–409. 40 indexed citations
18.
Morley, AA, et al.. (1981). Effect of total leucocyte count on whole blood filterability in patients with peripheral vascular disease.. Journal of Clinical Pathology. 34(2). 163–166. 35 indexed citations
19.
Seshadri, R., et al.. (1979). EFFECTIVE USE OF BLOOD IN ELECTIVE SURGICAL PROCEDURES. The Medical Journal of Australia. 2(11). 575–578. 28 indexed citations
20.
Morley, AA, et al.. (1978). Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulfan. Blood. 51(4). 601–610. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026